Journal for ImmunoTherapy of Cancer (Nov 2023)
226 ‘Off-the-shelf’ CD19-CAR-T cells generated from umbilical cord blood display superior anti-tumor fitness and lower pro-inflammatory activity as compared to peripheral blood-derived engineered T cells
Abstract
No abstracts available.